MERUS N V's ticker is MRUS and the CUSIP is N5749R100. A total of 113 filers reported holding MERUS N V in Q3 2023. The put-call ratio across all filers is 2.34 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $885,853 | +27.0% | 37,568 | +41.8% | 0.00% | 0.0% |
| Q2 2023 | $697,376 | +43.3% | 26,486 | +0.2% | 0.00% | 0.0% |
| Q1 2023 | $486,496 | +21.4% | 26,440 | +2.1% | 0.00% | 0.0% |
| Q4 2022 | $400,688 | -17.9% | 25,901 | +6.3% | 0.00% | 0.0% |
| Q3 2022 | $488,000 | -8.6% | 24,356 | +3.3% | 0.00% | 0.0% |
| Q2 2022 | $534,000 | -14.8% | 23,581 | -0.6% | 0.00% | 0.0% |
| Q1 2022 | $627,000 | -15.8% | 23,717 | +1.3% | 0.00% | 0.0% |
| Q4 2021 | $745,000 | +92.5% | 23,422 | +33.3% | 0.00% | – |
| Q3 2021 | $387,000 | – | 17,571 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynx1 Capital Management LP | 1,150,225 | $27,122,306 | 17.94% |
| COMMODORE CAPITAL LP | 4,428,072 | $104,413,938 | 12.20% |
| Medicxi Ventures Management (Jersey) Ltd | 1,600,000 | $37,728,000 | 12.04% |
| Aquilo Capital Management, LLC | 430,109 | $10,141,970 | 9.19% |
| Ally Bridge Group (NY) LLC | 221,384 | $5,220,235 | 6.13% |
| Fairmount Funds Management LLC | 1,881,345 | $44,362,115 | 5.34% |
| VR Adviser, LLC | 1,726,214 | $40,704,126 | 4.28% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 500,000 | $11,790,000 | 3.58% |
| DAFNA Capital Management LLC | 484,870 | $11,433,235 | 3.56% |
| Nan Fung Group Holdings Ltd | 137,038 | $3,231,356 | 2.62% |